Epidemics with Multistrain Interactions: The Interplay Between Cross Immunity and Antibody-Dependent Enhancement

Biology – Quantitative Biology – Populations and Evolution

Scientific paper

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

10 pages, 11 figures. Updated version

Scientific paper

This paper examines the interplay of the effect of cross immunity and antibody-dependent enhancement (ADE) in mutistrain diseases. Motivated by dengue fever, we study a model for the spreading of epidemics in a population with multistrain interactions mediated by both partial temporary cross immunity and ADE. Although ADE models have previously been observed to cause chaotic outbreaks, we show analytically that weak cross immunity has a stabilizing effect on the system. That is, the onset of disease fluctuations requires a larger value of ADE with small cross immunity than without. However, strong cross immunity is shown numerically to cause oscillations and chaotic outbreaks even for low values of ADE.

No associations

LandOfFree

Say what you really think

Search LandOfFree.com for scientists and scientific papers. Rate them and share your experience with other people.

Rating

Epidemics with Multistrain Interactions: The Interplay Between Cross Immunity and Antibody-Dependent Enhancement does not yet have a rating. At this time, there are no reviews or comments for this scientific paper.

If you have personal experience with Epidemics with Multistrain Interactions: The Interplay Between Cross Immunity and Antibody-Dependent Enhancement, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Epidemics with Multistrain Interactions: The Interplay Between Cross Immunity and Antibody-Dependent Enhancement will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFWR-SCP-O-727195

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.